These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
38 related articles for article (PubMed ID: 12458338)
1. Sequential observations on the occurrence of preneoplastic and neoplastic lesions in mouse colon treated with azoxymethane and dextran sodium sulfate. Suzuki R; Kohno H; Sugie S; Tanaka T Cancer Sci; 2004 Sep; 95(9):721-7. PubMed ID: 15471557 [TBL] [Abstract][Full Text] [Related]
2. Combination of atorvastatin with sulindac or naproxen profoundly inhibits colonic adenocarcinomas by suppressing the p65/β-catenin/cyclin D1 signaling pathway in rats. Suh N; Reddy BS; DeCastro A; Paul S; Lee HJ; Smolarek AK; So JY; Simi B; Wang CX; Janakiram NB; Steele V; Rao CV Cancer Prev Res (Phila); 2011 Nov; 4(11):1895-902. PubMed ID: 21764859 [TBL] [Abstract][Full Text] [Related]
3. Optimization of Erlotinib Plus Sulindac Dosing Regimens for Intestinal Cancer Prevention in an Apc-Mutant Model of Familial Adenomatous Polyposis (FAP). Ulusan AM; Rajendran P; Dashwood WM; Yavuz OF; Kapoor S; Gustafson TA; Savage MI; Brown PH; Sei S; Mohammed A; Vilar E; Dashwood RH Cancer Prev Res (Phila); 2021 Mar; 14(3):325-336. PubMed ID: 33277315 [TBL] [Abstract][Full Text] [Related]
8. Daikenchuto (TU-100) Suppresses Tumor Development in the Azoxymethane and APC Hasebe T; Matsukawa J; Ringus D; Miyoshi J; Hart J; Kaneko A; Yamamoto M; Kono T; Fujiya M; Kohgo Y; Wang CZ; Yuan CS; Bissonnette M; Musch MW; Chang EB Phytother Res; 2017 Jan; 31(1):90-99. PubMed ID: 27730672 [TBL] [Abstract][Full Text] [Related]
9. Anti-inflammatory drug resistance selects putative cancer stem cells in a cellular model for genetically predisposed colon cancer. Telang N Oncol Lett; 2018 Jan; 15(1):642-648. PubMed ID: 29434827 [TBL] [Abstract][Full Text] [Related]
10. The metabolism and pharmacokinetics of phospho-sulindac (OXT-328) and the effect of difluoromethylornithine. Xie G; Nie T; Mackenzie GG; Sun Y; Huang L; Ouyang N; Alston N; Zhu C; Murray OT; Constantinides PP; Kopelovich L; Rigas B Br J Pharmacol; 2012 Apr; 165(7):2152-66. PubMed ID: 21955327 [TBL] [Abstract][Full Text] [Related]
11. Mouse Models for Application in Colorectal Cancer: Understanding the Pathogenesis and Relevance to the Human Condition. Li C; Lau HC; Zhang X; Yu J Biomedicines; 2022 Jul; 10(7):. PubMed ID: 35885015 [TBL] [Abstract][Full Text] [Related]
12. Prognostic importance of increased cyclooxygenase-2 levels in colorectal carcinomas: a 5-year single-institution study. Okudur SS; Özer MT; Demirbaş S; Kalemoğlu M; Harlak A; Coşkun K; Eryılmaz M Eurasian J Med; 2008 Apr; 40(1):6-9. PubMed ID: 25610014 [TBL] [Abstract][Full Text] [Related]
13. Phosphosulindac (OXT-328) selectively targets breast cancer stem cells in vitro and in human breast cancer xenografts. Zhu C; Cheng KW; Ouyang N; Huang L; Sun Y; Constantinides P; Rigas B Stem Cells; 2012 Oct; 30(10):2065-75. PubMed ID: 22653497 [TBL] [Abstract][Full Text] [Related]
14. Prebiotic treatment reduced preneoplastic lesions through the downregulation of toll like receptor 4 in a chemo-induced carcinogenic model. Fukuda M; Komiyama Y; Mitsuyama K; Andoh A; Aoyama T; Matsumoto Y; Kanauchi O J Clin Biochem Nutr; 2011 Jul; 49(1):57-61. PubMed ID: 21765608 [TBL] [Abstract][Full Text] [Related]
15. Effects of long-term administration of sulindac on APC mRNA and apoptosis in colons of rats treated with azoxymethane. Kishimoto Y; Yashima K; Morisawa T; Ohishi T; Marumoto A; Sano A; Idobe-Fujii Y; Miura N; Shiota G; Murawaki Y; Hasegawa J J Cancer Res Clin Oncol; 2002 Nov; 128(11):589-95. PubMed ID: 12458338 [TBL] [Abstract][Full Text] [Related]
16. Molecular changes in the early stage of colon carcinogenesis in rats treated with azoxymethane. Kishimoto Y; Morisawa T; Hosoda A; Shiota G; Kawasaki H; Hasegawa J J Exp Clin Cancer Res; 2002 Jun; 21(2):203-11. PubMed ID: 12148579 [TBL] [Abstract][Full Text] [Related]
17. Strain-specific homeostatic responses during early stages of Azoxymethane-induced colon tumorigenesis in mice. Guda K; Marino JN; Jung Y; Crary K; Dong M; Rosenberg DW Int J Oncol; 2007 Oct; 31(4):837-42. PubMed ID: 17786315 [TBL] [Abstract][Full Text] [Related]
18. Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis. Reddy BS; Hirose Y; Lubet R; Steele V; Kelloff G; Paulson S; Seibert K; Rao CV Cancer Res; 2000 Jan; 60(2):293-7. PubMed ID: 10667579 [TBL] [Abstract][Full Text] [Related]
19. The effect of sulindac on colon polyps: circumvention of a transformed phenotype--a hypothesis. Waddell WR J Surg Oncol; 1994 Jan; 55(1):52-5. PubMed ID: 8289454 [TBL] [Abstract][Full Text] [Related]